Gerard Drewes

Active 1992–2024

72
Papers
26,679
Citations
57
h-index
72
i10-index

Citations

Citations per year for Gerard Drewes1967: 1 citations1968: 1 citations1973: 2 citations1984: 1 citations1987: 1 citations1988: 1 citations1991: 1 citations1992: 8 citations1993: 58 citations1994: 61 citations1995: 89 citations1996: 62 citations1997: 71 citations1998: 90 citations1999: 88 citations2000: 108 citations2001: 89 citations2002: 179 citations2003: 291 citations2004: 386 citations2005: 311 citations2006: 340 citations2007: 387 citations2008: 411 citations2009: 355 citations2010: 302 citations2011: 332 citations2012: 391 citations2013: 366 citations2014: 332 citations2015: 384 citations2016: 385 citations2017: 383 citations2018: 349 citations2019: 855 citations2020: 927 citations2021: 899 citations2022: 692 citations2023: 423 citations2024: 688 citations2025: 283 citations2026: 10 citations1969–1972: no citations, so these years are not shown1974–1983: no citations, so these years are not shown1985–1986: no citations, so these years are not shown1989–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,232 citing papers, 29.3% of this breakdownChina: 1,400 citing papers, 9.7% of this breakdownGermany: 1,316 citing papers, 9.1% of this breakdownUnited Kingdom: 1,293 citing papers, 9% of this breakdownCanada: 552 citing papers, 3.8% of this breakdownFrance: 483 citing papers, 3.3% of this breakdownSwitzerland: 367 citing papers, 2.5% of this breakdownSpain: 362 citing papers, 2.5% of this breakdownJapan: 359 citing papers, 2.5% of this breakdownAustralia: 353 citing papers, 2.4% of this breakdownIndia: 314 citing papers, 2.2% of this breakdownItaly: 313 citing papers, 2.2% of this breakdown
0%29.3%Other 21.5%

Fields

  • Biochemistry, Genetics and Molecular Biology58.4%
  • Medicine23.5%
  • Immunology and Microbiology5.1%
  • Chemistry5.1%
  • Computer Science2.6%
  • Neuroscience2.2%
  • Other3.1%

Topics

  • Bioinformatics and Genomic Networks6.1%
  • Alzheimer's disease research and treatments4%
  • Protein Degradation and Inhibitors3.8%
  • Computational Drug Discovery Methods3.4%
  • Ubiquitin and proteasome pathways2.5%
  • Protein Structure and Dynamics2.4%
  • Other77.8%

Coauthors

All papers

Open in search
  1. Tracking cancer drugs in living cells by thermal profiling of the proteome

    Authors: , , , , , , , , , , , , , , , - Science 2014 cited by 1,233

  2. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul R Thompson, Rab K. Prinjha, David M. Wilson - Nature Chemical Biology 2015 cited by 760

  3. Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry

    Authors: , , , , , , , , , , , , - Nature Protocols 2015 cited by 708

  4. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2011 cited by 1,532

  5. Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew Lindon, Gerard Drewes, Emmanuel H. Demont, Danette L. Daniels, Paola Grandi, Rab K. Prinjha, Mark A. Dawson - Science 2020 cited by 428

  6. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David M. Wilson - Nature 2012 cited by 968

  7. Functional organization of the yeast proteome by systematic analysis of protein complexes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gerard Drewes, Manfred Raida, Tewis Bouwmeester, Peer Bork, Bertrand Séraphin, Bernhard Küster, Gitte Neubauer, Giulio Superti‐Furga - Nature 2002 cited by 4,805

  8. Proteome survey reveals modularity of the yeast cell machinery

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert B. Russell, Giulio Superti‐Furga - Nature 2006 cited by 2,591

  9. The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elı́as Campo, Enrique Carrillo de Santa Pau, Lisa H. Chadwick, Kui Ming Chan, Wei Chen, Tom H. Cheung, Luca Chiapperino, Nak Hyen Choi, Ho‐Ryun Chung, Laura Clarke, Joseph M. Connors, Philippe Cronet, John Danesh, Manolis Dermitzakis, Gerard Drewes, Pawel Durek, Stephanie O. M. Dyke, Tomasz Dyląg, Connie J. Eaves, Peter Ebert, Roland Eils, Jürgen Eils, Catherine Ennis, Tariq Enver, Elise A. Feingold, Bärbel Felder, Anne C. Ferguson‐Smith, Jude Fitzgibbon, Paul Flicek, Roger Foo, Peter Fraser, Mattia Frontini, Eileen E. M. Furlong, Sitanshu Gakkhar, Nina Gasparoni, Gilles Gasparoni, Daniel H. Geschwind, Petar Glažar, Thomas Graf, Frank Grosveld, Xin‐Yuan Guan, Roderic Guigó, Marta Gut, Alf Hamann, Bok-Ghee Han, R. Alan Harris, Simon Heath, Kristian Helin, Jan G. Hengstler, Alireza Heravi‐Moussavi, Karl Herrup, Steven Hill, Jason A. Hilton, Benjamin C. Hitz, Bernhard Horsthemke, Ming Hu, Jooyeon Hwang, Nancy Y. Ip, Takashi Ito, Biola M. Javierre, Sasa Jenko, Thomas Jenuwein, Yann Joly, Steven J.M. Jones, Yae Kanai, Hee Gyung Kang, Aly Karsan, Alexandra K. Kiemer, Song Cheol Kim, Bong-Jo Kim and 130 more - Cell 2016 cited by 566

  10. Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2011 cited by 666

  11. A physical and functional map of the human TNF-α/NF-κB signal transduction pathway

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2004 cited by 1,028

  12. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacques Epelbaum, Marc Mercken, Eric Karran, Marcus Bantscheff, Gerard Drewes, Gérard Joberty, Dominique Campion, J-N Octave, Claudine Berr, Mark Lathrop, Patrick Callaerts, David M. A. Mann, Julie Williams, Luc Buée, Ilse Dewachter, Christine Van Broeckhoven, Philippe Amouyel, Dieder Moechars, Bart Dermaut, J-C Lambert - Molecular Psychiatry 2013 cited by 440

  13. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding

    Authors: , , , , - Neuron 1993 cited by 791

  14. Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo

    Authors: , , , , , , , , , , , , , - Acta Neuropathologica 2017 cited by 117

  15. MARK, a Novel Family of Protein Kinases That Phosphorylate Microtubule-Associated Proteins and Trigger Microtubule Disruption

    Authors: , , , , - Cell 1997 cited by 878

  16. Thermal proteome profiling monitors ligand interactions with cellular membrane proteins

    Authors: , , , , , , , , , , , , - Nature Methods 2015 cited by 319

  17. Biological plasticity rescues target activity in CRISPR knock outs

    Authors: , , , , , , , , , , , , , , , , , - Nature Methods 2019 cited by 237

  18. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2007 cited by 1,044

  19. Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Medicinal Chemistry 2015 cited by 234

  20. Microtubule-associated Protein/Microtubule Affinity-regulating Kinase (p110mark)

    Authors: , , , , , , , , , - Journal of Biological Chemistry 1995 cited by 376

  21. Click chemistry enables preclinical evaluation of targeted epigenetic therapies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2017 cited by 143

  22. Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pattaraporn Vanachayangkul, Chek Shik Lim, Jeremy N. Burrows, Michael J. Witty, Kennan C. Marsh, Christophe Bodenreider, Rosemary Rochford, Suresh Solapure, Marı́a Belén Jiménez-Dı́az, Sergio Wittlin, Susan A. Charman, Cristina Donini, Brice Campo, Lyn‐Marié Birkholtz, Kirsten K. Hanson, Gerard Drewes, Clemens H. M. Kocken, Michael J. Delves, Didier Leroy, David A. Fidock, David Waterson, Leslie J. Street, Kelly Chibale - Science Translational Medicine 2017 cited by 272

  23. Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kevin D. Read, Ian H. Gilbert - Nature 2018 cited by 145

  24. The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2022 cited by 46